Spotline V-Assure Platform Enables Pre-Validation for Veeva Basics Releases

SAN JOSE, Calif., May 20, 2025 /PRNewswire/ — Spotline, Inc., a Veeva-certified product, services, and AI partner, today announced that Veeva Systems is using its V-Assure platform to enable faster, pre-validated software releases for Veeva Basics—the pre-configured solution designed to help emerging biotechs achieve rapid deployment and built-in GxP compliance.

Veeva used Spotline’s V-Assure platform to accelerate the delivery of the last three releases of Veeva Basics for clinical, regulatory, and quality. V-Assure automated testing for these applications, providing emerging biotech customers with documentation to support the Basics Production Qualification.

How Spotline Supports Veeva Basics’ Mission for Biotech Speed and Compliance

To help Veeva deliver Veeva Basics efficiently as a turnkey application, Spotline:

• Built and maintained reusable, automated test libraries using V-Assure
• Adapted scripts rapidly to reflect evolving release requirements
• Executed complete, automated validation cycles before each release
• Provided automated re-execution of qualification for each Veeva Basics maintenance release.

This proactive, automation-first approach helped ensure that every release was audit- and inspection-ready to support accelerated development and release management of Veeva Basics.

“By using Spotline’s V-Assure testing platform, we can deliver complete qualification documentation across our Veeva Basics applications,” said Steve Harper, General Manager of Veeva Basics. “Automating testing helps us to move faster and provide testing and documentation on behalf of our customers. This saves time and effort while accelerating application delivery for emerging biotech.”

Automated Validation Across Veeva Basics Applications
With Spotline’s V-Assure one-touch automated testing within each release cycle, Veeva successfully delivered audit- and inspection-ready validation documentation for its Veeva Basics applications in clinical, regulatory, and quality. Through the validation process, Veeva automated more than 500 test case executions across its Veeva Basics applications.

“Supporting the Veeva Basics team through three major releases has showcased how automated validation—when done right—can deliver speed and reliability,” said Sid Sahoo, CEO of Spotline, Inc. “V-Assure is helping life sciences organizations modernize their validation processes and unlock faster adoption of compliant solutions.”

Meet Us at the Veeva R&D and Quality Summits
Spotline will demonstrate the latest version of V-Assure, including its enhanced integrations with Veeva Validation Management, at the upcoming Veeva R&D and Quality Summits in Europe and the U.S.

Attendees are encouraged to schedule a demo at www.spotline.com/v-assure to explore how V-Assure can transform their validation operations.

About Spotline Inc.
Spotline Inc. is a Veeva-certified partner delivering innovative validation, automation, and integration solutions for life sciences. Through products like V-Assure, Spotline enables biotech and pharmaceutical companies to accelerate compliance, reduce risk, and focus on strategic innovation.

For more information about Spotline, please visit www.spotline.com

Contact Info
Jeff Andrist
Spotline Inc.
Email: info@spotline.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/spotline-v-assure-platform-enables-pre-validation-for-veeva-basics-releases-302459936.html

SOURCE Spotline, Inc.